| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
50,000,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile scPharmaceuticals is a pharmaceutical company. Co.'s primary product candidate, FUROSCIX, consists of its formulation of furosemide delivered via an on-body infusor and is under development for treatment of congestion in patients with worsening heart failure who display reduced responsiveness to oral diuretics and do not require hospitalization.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
500,000 |
500,000 |
| Total Buy Value |
$0 |
$0 |
$2,000,000 |
$2,000,000 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
1 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nokes Rachael |
CFO and Treasurer |
• – – |
2025-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
88,445 |
156,061 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2025-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
440,847 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2025-01-03 |
4 |
D |
$3.56 |
$47,544 |
D/D |
(13,360) |
240,847 |
|
- |
|
| Nokes Rachael |
CFO and Treasurer |
• – – |
2025-01-03 |
4 |
D |
$3.56 |
$18,630 |
D/D |
(5,235) |
67,616 |
|
- |
|
| Schaeffer Leonard D |
|
– • – |
2024-08-26 |
4 |
OE |
$1.66 |
$29,308 |
D/D |
11,347 |
54,451 |
|
- |
|
| Orbimed Genesis Gp Llc |
10% Owner |
– – • |
2024-08-13 |
4 |
B |
$4.00 |
$2,000,000 |
I/I |
500,000 |
252,858 |
1.5 |
- |
|
| Nokes Rachael |
CFO and Treasurer |
• – – |
2024-08-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,445 |
72,851 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
113,560 |
254,207 |
|
- |
|
| Nokes Rachael |
CFO and Treasurer |
• – – |
2024-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
41,840 |
62,406 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2024-01-02 |
4 |
D |
$6.39 |
$31,579 |
D/D |
(4,942) |
140,647 |
|
- |
|
| Nokes Rachael |
CFO and Treasurer |
• – – |
2024-01-02 |
4 |
D |
$6.39 |
$6,563 |
D/D |
(1,027) |
20,566 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2023-01-19 |
4 |
A |
$6.14 |
$409,323 |
D/D |
66,665 |
145,589 |
|
- |
|
| Nokes Rachael |
See Remarks |
• – – |
2023-01-19 |
4 |
A |
$6.14 |
$71,838 |
D/D |
11,700 |
21,593 |
|
- |
|
| Orbimed Genesis Gp Llc |
10% Owner |
– – • |
2022-11-25 |
4 |
B |
$5.25 |
$4,002,495 |
I/I |
762,380 |
5,328,328 |
1.5 |
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2022-10-10 |
4 |
S |
$4.09 |
$2,300,486 |
I/I |
(562,466) |
410,268 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2022-10-07 |
4 |
D |
$4.98 |
$51,234 |
D/D |
(10,288) |
78,924 |
|
- |
|
| Tucker John H |
President and CEO |
• • – |
2022-10-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
42,250 |
89,212 |
|
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2022-10-06 |
4 |
S |
$5.02 |
$188,421 |
I/I |
(37,534) |
497,304 |
|
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2022-09-07 |
4 |
S |
$4.75 |
$950,000 |
I/I |
(200,000) |
503,112 |
|
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2022-09-06 |
4 |
S |
$5.52 |
$146,953 |
I/I |
(26,622) |
533,285 |
|
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2022-04-11 |
4 |
S |
$5.00 |
$1,350,000 |
I/I |
(270,000) |
537,301 |
|
- |
|
| Khattar Jack A. |
Director |
– • – |
2021-12-03 |
4 |
B |
$3.91 |
$19,569 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| Tucker John H |
President and CEO |
• • – |
2021-12-03 |
4 |
B |
$3.96 |
$39,553 |
D/D |
10,000 |
46,962 |
2.81 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2021-03-15 |
4 |
S |
$7.03 |
$777,788 |
I/I |
(110,588) |
2,727,446 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2021-03-12 |
4 |
S |
$7.22 |
$284,816 |
I/I |
(39,469) |
2,838,034 |
|
- |
|
51 Records found
|
|
Page 1 of 3 |
|
|
